American hospital formulary service, Volume 90
Published by authority of the Board of Directors of the American Society of Hospital Pharmacists, 1990 - Medicine
Arranged by AHFS pharmacologic - therapeutic classification, drug monographs include: chemistry and stability, pharmacology, pharmacokinetics, uses, cautions, toxicity, drug interactions, laboratory test interferences, dosage and administration (including dosage in renal impairment), and preparations. Covers drugs available in the U.S. Also includes general statements on groups of drugs as well as data on older and prototype drugs.
2 pages matching inhibited in vitro in this book
Results 1-2 of 2
What people are saying - Write a review
We haven't found any reviews in the usual places.
2-oxoquazepam 400-mg oral dose active in vitro adenosine adverse GI effects amoxicillin bacteria benzodiazepines Biological Designations Blvd catarrhalis caused by susceptible cefaclor cefixime cefixime concentrations Cefixime is active cefixime therapy cephalosporins clinically important clinicians suggest co-trimoxazole concentrations of cefixime Corp creatinine clearances Cutter Biological Dosage and Administration dose of cefixime Drug and Biological Enterobacteriaceae enterococci Epoetin alfa Following oral administration Genentech healthy adults influenzae inhibited in vitro lactamases Manufacturers List metabolites mL/minute name not established Orphan Drug otitis media patients receiving cefixime peak serum concentrations Pharmacal Pharmaceuticals Pharmaceuticals P. O. Box Pharmacokinetics pneumoniae Point San Bruno quazepam REACTION renal function reported reportedly resistant to cefixime respiratory tract infections staphylococci strains streptococci studies susceptibility to cefixime susceptible organisms tablets trade name treatment of otitis treatment of uncomplicated twice daily Ug/mL uncomplicated UTIs urinary tract infections vitro vitro by cefixime zidovudine